University of Tasmania
Browse

Personalized medicine and stroke prevention: where are we?

Download (141.09 kB)
Version 2 2025-03-19, 00:00
Version 1 2023-05-18, 15:16
journal contribution
posted on 2025-03-19, 00:00 authored by J Kim, AG Thrift, Mark NelsonMark Nelson, CF Bladin, DA Cadilhac
There are many recommended pharmacological and non-pharmacological therapies for the prevention of stroke, and an ongoing challenge is to improve their uptake. Personalized medicine is seen as a possible solution to this challenge. Although the use of genetic information to guide health care could be considered as the apex of personalized medicine, genetics is not yet routinely used to guide prevention of stroke. Currently personalized aspects of prevention of stroke include tailoring interventions based on global risk, the utilization of individualized management plans within a model of organized care, and patient education. In this review we discuss the progress made in these aspects of prevention of stroke and present a case study to illustrate the issues faced by health care providers and patients with stroke that could be overcome with a personalized approach to the prevention of stroke.

History

Publication title

Vascular Health and Risk Management

Volume

11

Issue

0

Pagination

601-611

ISSN

1176-6344

Department/School

Menzies Institute for Medical Research

Publisher

Dove Medical Press

Publication status

  • Published online

Place of publication

New Zealand

Rights statement

© 2015 Kim et al. Licensed under Creative Commons Attribution – Non Commercial unported v3.0 (CC BY NC)http://creativecommons.org/licenses/by-nc/3.0/.

Socio-economic Objectives

200199 Clinical health not elsewhere classified

UN Sustainable Development Goals

3 Good Health and Well Being

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC